Scientists in the field of human fertility are coming under pressure to rein in maverick researchers whose experiments push ethical boundaries and caused public revulsion this week.
Critics say the lack of agreed standards is damaging the reputation of more mainstream researchers. While some countries have stringent guidelines backed up by enforceable legislation, others have none at all.
In those cases, given the will and the cash, anything goes. Eggs and sperm, donated in good faith, can be used in whatever research the scientists desire. Paul Serhal, director of the assisted conception unit at University College London, said fertility research was facing a critical question: "How do we prevent people doing monstrous things?"
The ethical crisis was thrown into vivid relief this week at a European fertility conference in Madrid when an Israeli-Dutch team reported they had matured eggs from an aborted foetus in the hope of finding a new source of eggs for couples needing treatment. Alarmed headlines were followed the next day with the news that a private fertility clinic in America had created bizarre hybrid human embryos called chimeras by merging male cells with female embryos.
Neither experiment would have been allowed in the UK, says the human fertility and embryology authority (HFEA). But the hybrid embryos had received ethical approval in the US and the foetal eggs research was approved in Israel. Both studies were presented in Madrid at the European Society of Human Reproduction and Embryology's annual meeting.
Most scientists are in no doubt that the studies, in particular the work on chimeric embryos, have delivered a blow to the public's confidence in fertility research.
"Studies of this nature are going to backfire on mainstream scientists who are doing genuine scientific work," said Serhal. "They will tarnish our image."
Only the HFEA can issue licenses for research on embryos in the UK. Certain areas are banned, such as placing a human embryo in an animal. The authority would not have approved the chimera work. "We think it's illegal," said Alison Cook of the HFEA. "The [HFEA] Act says that we are not allowed to alter the genetic material of any embryonic cell. We believe the spirit of the law would not allow you to put in an extra cell."
The prospect of a child being born from an egg from an aborted foetus would also be unacceptable to the authority because of the difficulty for the child coming to terms with its origins. All IVF (in vitro fertilization) clinics must consider above all the interests of the children they may help create. But the framework in the UK is not mirrored elsewhere.
"The country you most need to regulate is the one that's least likely to accept regulation -- the United States," said fertility expert Robert Winston at Hammersmith hospital, west London. "The problem is that they do not in general want central regulation, so you have different rules in different states."
Federal law washes its hands of embryo research by a refusal to fund any of it, so the work is left to private clinics and research institutes governed by the patchwork of state laws. A few states ban embryo research because of the passions evoked over abortion and the right to life. Elsewhere there is little restraint.
Norbert Gleicher, whose team created the chimera foetuses, is the founder and head of the for Human Reproduction, which has clinics in Chicago and New York. He appeared to have no trouble getting ethical approval for the work, which was intended to investigate a technique for curing genetic diseases.
Scientists are divided on how best to tackle the maverick element of fertility researchers or whether they even need to be tackled.
"The only way to rein them in is to have a body like the HFEA in different countries," said Serhal. "When you know there is someone breathing down your neck, you're going to think twice, if not more, before doing something stupid."
But there is no guarantee a global HFEA would be the answer. In the UK, some private clinics flout the fertility guidelines but do not seem to be penalized.
"They aren't even being threatened with having their licenses taken away," said Allan Templeton of the Royal College of Obstetricians and Gynecologists.
Chinese President Xi Jinping (習近平) is to visit Russia next month for a summit of the BRICS bloc of developing economies, Chinese Minister of Foreign Affairs Wang Yi (王毅) said on Thursday, a move that comes as Moscow and Beijing seek to counter the West’s global influence. Xi’s visit to Russia would be his second since the Kremlin sent troops into Ukraine in February 2022. China claims to take a neutral position in the conflict, but it has backed the Kremlin’s contentions that Russia’s action was provoked by the West, and it continues to supply key components needed by Moscow for
Japan scrambled fighter jets after Russian aircraft flew around the archipelago for the first time in five years, Tokyo said yesterday. From Thursday morning to afternoon, the Russian Tu-142 aircraft flew from the sea between Japan and South Korea toward the southern Okinawa region, the Japanese Ministry of Defense said in a statement. They then traveled north over the Pacific Ocean and finished their journey off the northern island of Hokkaido, it added. The planes did not enter Japanese airspace, but flew over an area subject to a territorial dispute between Japan and Russia, a ministry official said. “In response, we mobilized Air Self-Defense
CRITICISM: ‘One has to choose the lesser of two evils,’ Pope Francis said, as he criticized Trump’s anti-immigrant policies and Harris’ pro-choice position Pope Francis on Friday accused both former US president Donald Trump and US Vice President Kamala Harris of being “against life” as he returned to Rome from a 12-day tour of the Asia-Pacific region. The 87-year-old pontiff’s comments on the US presidential hopefuls came as he defied health concerns to connect with believers from the jungle of Papua New Guinea to the skyscrapers of Singapore. It was Francis’ longest trip in duration and distance since becoming head of the world’s nearly 1.4 billion Roman Catholics more than 11 years ago. Despite the marathon visit, he held a long and spirited
The pitch is a classic: A young celebrity with no climbing experience spends a year in hard training and scales Mount Everest, succeeding against some — if not all — odds. French YouTuber Ines Benazzouz, known as Inoxtag, brought the story to life with a two-hour-plus documentary about his year preparing for the ultimate challenge. The film, titled Kaizen, proved a smash hit on its release last weekend. Young fans queued around the block to get into a preview screening in Paris, with Inoxtag’s management on Monday saying the film had smashed the box office record for a special cinema